CITIGROUP INC - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 28 filers reported holding ALDEYRA THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$755,081
+7.1%
113,036
+34.6%
0.00%
Q2 2023$704,802
+46.1%
84,005
+72.9%
0.00%
Q1 2023$482,459
+54.7%
48,586
+8.4%
0.00%
Q4 2022$311,947
+1055.4%
44,820
+794.3%
0.00%
Q3 2022$27,000
-98.2%
5,012
-98.6%
0.00%
-100.0%
Q2 2022$1,464,000
+12100.0%
367,030
+14321.6%
0.00%
Q1 2022$12,000
-98.8%
2,545
-99.0%
0.00%
Q4 2021$1,012,000
+21.2%
253,062
+166.0%
0.00%
Q3 2021$835,000
-65.2%
95,146
-55.1%
0.00%
-100.0%
Q2 2021$2,400,000
-12.7%
211,796
-8.5%
0.00%
-50.0%
Q1 2021$2,750,000
+807.6%
231,491
+423.8%
0.00%
Q4 2020$303,000
+80.4%
44,193
+95.0%
0.00%
Q3 2020$168,000
+572.0%
22,658
+271.5%
0.00%
Q2 2020$25,000
-10.7%
6,099
-46.5%
0.00%
Q1 2020$28,000
-48.1%
11,399
+22.6%
0.00%
Q4 2019$54,000
+80.0%
9,298
+64.6%
0.00%
Q3 2019$30,000
-30.2%
5,649
-21.1%
0.00%
Q2 2019$43,000
-29.5%
7,158
+6.3%
0.00%
Q1 2019$61,000
+38.6%
6,734
+26.9%
0.00%
Q4 2018$44,000
-99.7%
5,306
-99.5%
0.00%
-100.0%
Q3 2018$14,093,000
+78194.4%
1,021,222
+44533.8%
0.01%
Q2 2018$18,0002,288
+57100.0%
0.00%
Q1 2016$04
-90.5%
0.00%
Q3 2014$0420.00%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Prosight Management, LP 908,488$6,232,0002.88%
Knoll Capital Management, LLC 569,405$3,906,0002.66%
Mesirow Financial Investment Management, Inc. 64,698$443,828,0001.40%
Ghost Tree Capital, LLC 650,000$4,459,0000.99%
Johnson & Johnson Innovation - JJDC, Inc. 594,834$4,081,0000.53%
Perceptive Advisors 6,285,458$43,118,0000.46%
Affinity Asset Advisors, LLC 100,000$686,0000.36%
ACUTA CAPITAL PARTNERS, LLC 192,500$1,321,0000.36%
Avidity Partners Management LP 1,435,000$9,844,0000.32%
APOGEM CAPITAL LLC 55,821$383,0000.26%
View complete list of ALDEYRA THERAPEUTICS INC shareholders